FBXW7 and colorectal carcinoma: Regarding gene mutation patterns, recent studies have determined that increased mutation in KRAS and FBXW7 have been implicated as immunosuppressive biomarkers that play a role in poor immunotherapeutic responses in CRC [46, 47].